Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight management.
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment[1] ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists[2], or GLP-1.
Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household...